Results 171 to 180 of about 38,932 (287)

The Evolution of Medications for Obesity Management

open access: yesJGH Open, Volume 10, Issue 9, September 2026.
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley   +1 more source

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine. [PDF]

open access: yesToxicol Rep
Seltzer J   +7 more
europepmc   +1 more source

Prevalence, Patterns and Implications of Chemsex Substance Use Among Gay and Bisexual Men Who Have Sex With Men: A Cohort‐Collaboration Between the Swiss HIV Cohort Study and the SwissPrEPared Study

open access: yesJournal of the International AIDS Society, Volume 29, Issue 9, September 2026.
ABSTRACT Introduction Global awareness to chemsex, a specific form of sexualized psychoactive substance (“chems”) use among gay, bisexual and other men who have sex with men (gbMSM), is increasing. We aimed to assess prevalence, patterns and implications of “chems” use on chemsex‐related outcomes.
Bashkim Jaha   +14 more
wiley   +1 more source

Assessing mortality risk in narcolepsy: Evidence from population studies

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Narcolepsy is a chronic neurologic sleep disorder associated with excessive daytime sleepiness, cataplexy, and a higher prevalence of cardiovascular and psychiatric comorbidities. While these factors may predispose individuals to adverse events, observational studies evaluating mortality in narcolepsy have yielded inconsistent results.
Nawris Alhassan   +2 more
wiley   +1 more source

Hepatitis C Micro‐Elimination in a Deprived Coastal Town: Lessons From Blackpool

open access: yesPublic Health Challenges, Volume 5, Issue 3, September 2026.
By making hepatitis C virus (HCV) testing a routine part of care, Blackpool's drug and alcohol services dramatically improved HCV diagnosis and treatment and achieved HCV micro‐elimination. Continued commitment to this new way of working will be essential to sustain these gains.
Sarah E. Blagden   +2 more
wiley   +1 more source

Predictors of clinically diagnosed premature ventricular complexes in acute care settings: a cohort study. [PDF]

open access: yesEuropace
Noubiap JJ   +6 more
europepmc   +1 more source

Evaluation of illicit drug contaminants in seized cannabis in Arizona and California, 2023–2024

open access: yesJournal of Forensic Sciences, Volume 71, Issue 5, Page 2359-2363, September 2026.
Abstract Despite public health concerns, fentanyl, cocaine, and other illicit drug contaminants remain largely understudied in unregulated cannabis. Here, we developed an analytical method to quantify a panel of common illicit drugs in cannabis and tested the law enforcement seizures in Arizona and California in evaluation of the illicit drug ...
Beckner Andersano   +3 more
wiley   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

open access: yesAddiction, Volume 121, Issue 9, Page 2275-2283, September 2026.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy